Big Pharma Wanted To Control NMN, Because It Addresses WHY We Age At The Cellular Level

In November 2022, the FDA quietly issued a letter that changed the supplement industry overnight. The letter declared that NMN, a molecule shown across more than 40 clinical trials to raise cellular NAD+ levels by up to 142% in just two weeks, was no longer permitted for sale as a dietary supplement in the United States.

Within months, Amazon pulled every NMN listing from its platform. Walmart stopped carrying it. GNC followed soon after. A category that had been quietly building for nearly a decade was, for all practical purposes, erased from the largest retail shelves in the country.

The official reason given was a regulatory technicality. According to the agency, once a substance is authorized for investigation as a new drug, it can no longer be classified as a dietary supplement under the 1994 Dietary Supplement Health and Education Act. That is the rule the FDA cited.

Here is what the FDA did not announce from the rooftops. The company that triggered the reclassification, the company that filed the new drug application that started the entire chain of events, was co-founded by Harvard genetics professor David Sinclair. The company is called Metro International Biotech. Their proprietary version of NMN is called MIB-626. And they are pursuing exclusive pharmaceutical rights over the molecule that addresses the actual cause of cellular aging.

Why Your Cells Are Running Out Of Fuel

Most people think of aging as something that happens to your skin first. The wrinkles around your eyes. The gray hair at your temples. The way your back hurts a little more when you bend down to tie your shoes. That is biological aging, the version you can see in the mirror.

Underneath that surface, something deeper is happening. Your cells are running out of fuel.

NAD+ is a coenzyme that lives inside every cell in your body. It is what your mitochondria use to produce ATP, the actual energy currency your body runs on. Every blink, every breath, every heartbeat traces back to NAD+ powering your cells.

By the time you reach middle age, your NAD+ levels have already dropped by roughly 50% from where they were in your twenties. By 60, that number can fall even further. The decline is one of the most consistent findings in aging research over the last two decades, documented across human skin samples, blood samples, and cerebrospinal fluid.

This drop happens for two reasons working at the same time. Your body produces less NAD+ as you age, and two enzymes called PARP and CD38 become more active and start burning through whatever NAD+ you have left at faster and faster rates.

You are not just running out of fuel. The leaks in the tank are getting bigger.

The gap between how old you look and how old your cells actually are is the gap that matters. You can wear sunscreen and lift weights and eat clean. None of it stops what is happening inside your mitochondria. The fuel is draining, and the older you get, the faster it drains.

What 40+ Clinical Trials Actually Showed

Researchers spent more than a decade looking for a way to refill the cellular tank. Vitamin B3 produced modest increases in NAD+ over time, and niacinamide showed some signal in older adults, but neither came close to what NMN started showing once it hit the lab tables.

NMN is short for Nicotinamide Mononucleotide. It is a direct precursor to NAD+, which means your body converts it almost immediately into the coenzyme your cells are running out of. When you swallow NMN, you are essentially feeding your cells the raw material they need to rebuild their own fuel supply.

In a landmark 2022 dose-response trial registered as NCT04823260, researchers gave 80 middle-aged adults different daily amounts of NMN over 60 days. Three doses were tested against placebo: 300mg, 600mg, and 900mg. The 600mg group produced the highest measured improvements in both blood NAD+ levels and physical performance on the 6-minute walk test. All three doses raised NAD+ in the blood. None of them produced serious adverse effects.

Then in 2025, the RENEW Study delivered something even more meaningful. A 60-day trial using 500mg of NMN combined with synergistic ingredients produced a 44% increase in intracellular NAD+, and that distinction is the one that actually changes the conversation. Blood NAD+ tells you what is circulating in your bloodstream. Intracellular NAD+ tells you what is actually inside your cells, available for energy production, DNA repair, and the activation of longevity genes called sirtuins.

By January 2026, another trial pushed the bar further. A 14-day study using 900mg to 1,000mg of NMN reportedly raised blood NAD+ levels by up to 142%.

These were not minor signals. These were the kind of results that get the attention of pharmaceutical companies looking for the next blockbuster.

The Quiet Reclassification

In late 2021, Metro International Biotech LLC, a Massachusetts pharmaceutical company that David Sinclair helped co-found, filed an investigational new drug application with the FDA for a proprietary form of NMN called MIB-626.

Filing an IND application triggers a specific clause buried inside the 1994 Dietary Supplement Health and Education Act. Once a substance is authorized for investigation as a new drug, it can no longer be classified as a dietary supplement. That is federal law, and it cuts in only one direction.

The FDA had previously reviewed NMN as a New Dietary Ingredient and acknowledged the notification without objection. The agency knew companies were selling NMN supplements. They did not raise public concerns. They did not warn consumers. They did not say a word.

Then Metro Biotech filed.

On November 4, 2022, the FDA sent a letter to Inner Mongolia Kingdomway Pharmaceutical, an NMN ingredient supplier. The letter reversed the agency's position and declared that NMN was now excluded from the definition of a dietary supplement. The reason cited was that NMN had been "authorized for investigation as a new drug" and was therefore subject to the drug exclusion clause.

The supplement industry was blindsided. The Council for Responsible Nutrition called the decision unprecedented. The Natural Products Association filed a citizen petition demanding the FDA reverse course. The agency responded that it had not reached a decision "due to competing agency priorities" and continued to enforce the ban.

David Sinclair publicly distanced himself from the controversy in a statement on Twitter, noting that he is not "an owner, cofounder, investor, shareholder, marketer, spokesperson or sponsor of any company that sells NAD boosters as supplements." He confirmed his role as co-founder of Metro Biotech and chair of its scientific advisory board, while emphasizing that the company is pursuing FDA-approved drug status for NMN.

Critics in the longevity research community saw it differently. Dr. Brad Stanfield publicly accused Metro Biotech of "lobbying the FDA to ban NMN so they can sell their own proprietary blend." Dr. Charles Brenner, a respected NAD+ biochemist, suggested the goal was less about exclusive sales and more about being able to call themselves "a clinical stage company that could be invested in or sold."

However you read the motivation, the result was the same. The molecule with the strongest clinical data for addressing cellular aging was suddenly off the shelves of every major U.S. retailer, and the only company positioned to legally control NMN as a regulated drug was the one that had triggered the reclassification.

What This Means For You

Here is the part most consumers do not realize. The FDA's reclassification did not make NMN illegal. It did not make it unsafe. It made it harder to find on the shelves of Amazon and Walmart, while smaller, independent supplement makers continue selling it lawfully under current enforcement guidance.

The clinical data on NMN never changed. Forty-plus human trials, dose-response curves, intracellular NAD+ measurements, safety profiles up to 1,250mg per day. None of that was rescinded. The science only got stronger.

What changed was access. And what stayed the same was the underlying problem. Your cells still produce less NAD+ every year. Your PARP and CD38 enzymes still burn through whatever you have left at accelerating rates. The cellular fuel gauge still drops, regardless of what the FDA does or does not allow on the shelves of the largest retailers.

Why Most NMN Supplements Still Fall Short

Even before the FDA controversy, most NMN supplements on the market had a quiet flaw the clinical research had already identified. They contained NMN by itself.

NMN works through your body's methylation pathway, which means every NAD+ molecule produced costs you a methyl group. Take enough straight NMN over a long enough period of time, and you can deplete the methyl groups your body uses for hundreds of other functions, from neurotransmitter balance to detoxification. The science on this is not fringe. It is documented in peer-reviewed methylation research.

That is why serious longevity researchers do not recommend NMN by itself. They recommend NMN paired with TMG (trimethylglycine), which donates the methyl groups your body uses up. They recommend pairing it with resveratrol, which activates SIRT1, a longevity gene that works in tandem with NAD+. They recommend quercetin, which clears senescent cells and amplifies the cellular renewal NMN supports.

That is the four-part stack the research points toward. And until recently, almost no commercial supplement contained all four.

Cata-Kor NMN became available in the United States on December 1, 2025. Within four months, it became the #1 NMN supplement on TikTok Shop with over 100,000 units sold and the #1 NMN best seller on Amazon. In February 2026, the formula received NSF certification under NSF/ANSI 173, the American National Standard for dietary supplements that covers manufacturing quality, purity, and label accuracy.

That last part matters more than most consumers realize. NSF certification is not a marketing logo. It is an independent third-party audit that verifies what is actually inside the bottle matches what is on the label, that the ingredients are tested for heavy metals and contaminants, and that the manufacturing facility meets cGMP standards. Most NMN supplements you find online have no such verification. Cata-Kor went and got it.